KRTL Teams Up With Yuhan To Develop Cannabinoid-Based Products For US And Korean Commercial Markets
KRTL International Corp and KRTL Biotech Inc., a wholly owned subsidiaries of KRTL Holding Group, Inc. (OTCPK:KRTL) have entered into a memorandum of understanding for the development of industry-differentiated commercial CBD and other cannabinoid based products with Yuhan Care, a subsidiary of
